Actinium Pharmaceuticals
ATNM
ATNM
43 hedge funds and large institutions have $17.1M invested in Actinium Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.02% more ownership
Funds ownership: 8.56% → 9.57% (+1%)
7% more call options, than puts
Call options by funds: $4.62M | Put options by funds: $4.32M
Holders
43
Holding in Top 10
–
Calls
$4.62M
Puts
$4.32M
Top Buyers
| 1 | +$417K | |
| 2 | +$332K | |
| 3 | +$274K | |
| 4 |
D.E. Shaw & Co
New York
|
+$249K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$235K |
Top Sellers
| 1 | -$406K | |
| 2 | -$272K | |
| 3 | -$177K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$174K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$36.1K |